In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback